RVL Pharmaceuticals plc Current Assets
RVL Pharmaceuticals plc had Current Assets of $25.75 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-08-14
- 2023-06-30: Assets, Current $25.75M.
- 2023-03-31: Assets, Current $38.35M.
- 2022-12-31: Assets, Current $56.98M.
- 2022-09-30: Assets, Current $70.91M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2023-06-30 | $25.75M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $38.35M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $56.98M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $70.91M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $40.19M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $59.33M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $59.38M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $23.39M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $249.48M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $161.35M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $173.15M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $176.17M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $186.79M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $189.66M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $172.63M 8-K · filed 2021-09-08 | |
| 2019-09-30 | $167.30M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $173.97M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $163.96M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $172.36M 10-K · filed 2020-03-19 | $172.39M 10-K · filed 2019-03-28 |
| 2018-09-30 | $149.32M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $114.60M 8-K · filed 2019-12-20 | $115.14M 10-Q · filed 2018-11-08 |